BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1
2568 results:

  • 1. In Vitro Antiviral and Anticancer Effects of Tanacetum sinaicum Essential Oil on Human Cervical and breast cancer.
    Sheashea AA; Ahmed FA; El Zayat E; Ebeed BW; Elberry MH; Hassan ZKM; Hafez MM
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1457-1471. PubMed ID: 38680008
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development of a Novel, Potent, and Selective Sialyltransferase Inhibitor for Suppressing cancer Metastasis.
    Tsai HE; Chen CL; Chang TT; Fu CW; Chen WC; Perez SJLP; Hsiao PW; Tai MH; Li WS
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673867
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit.
    Engström T; Ekholm M; Fernö M; Lundgren C; Nordenskjöld B; Stål O; Bendahl PO; Tutzauer J; Rydén L
    Acta Oncol; 2024 Apr; 63():125-136. PubMed ID: 38587062
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Challenges in Diagnosis and Treatment of Male Hypogonadism.
    Purnamasari D
    Acta Med Indones; 2024 Jan; 56(1):1-2. PubMed ID: 38561883
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cytotoxic effect of Rotheca serrata on cancer cell lines MCF-7 and neuroblastoma SH-SY5Y.
    Gadade JP; Patil SA
    J Cancer Res Ther; 2024 Jan; 20(1):181-188. PubMed ID: 38554318
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive breast cancer with Brain Metastases.
    Wang C; Xiang J; Zhang Q; Li J; Liu Y; Liu J
    Drug Des Devel Ther; 2024; 18():909-917. PubMed ID: 38545432
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Ribociclib plus Endocrine Therapy in Early breast cancer.
    Slamon D; Lipatov O; Nowecki Z; McAndrew N; Kukielka-Budny B; Stroyakovskiy D; Yardley DA; Huang CS; Fasching PA; Crown J; Bardia A; Chia S; Im SA; Ruiz-Borrego M; Loi S; Xu B; Hurvitz S; Barrios C; Untch M; Moroose R; Visco F; Afenjar K; Fresco R; Severin I; Ji Y; Ghaznawi F; Li Z; Zarate JP; Chakravartty A; Taran T; Hortobagyi G
    N Engl J Med; 2024 Mar; 390(12):1080-1091. PubMed ID: 38507751
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [cancer incidence and mortality in China, 2022].
    Zheng RS; Chen R; Han BF; Wang SM; Li L; Sun KX; Zeng HM; Wei WW; He J
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):221-231. PubMed ID: 38468501
    [No Abstract]    [Full Text] [Related]  

  • 9. Validation of primary and outcome data quality in a Swedish population-based breast cancer quality registry.
    Palmér S; Blomqvist C; Holmqvist M; Lindman H; Lambe M; Ahlgren J
    BMC Cancer; 2024 Mar; 24(1):329. PubMed ID: 38468209
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long-Term Effect of Randomization to Calcium and Vitamin D Supplementation on Health in Older Women : Postintervention Follow-up of a Randomized Clinical Trial.
    Thomson CA; Aragaki AK; Prentice RL; Stefanick ML; Manson JE; Wactawski-Wende J; Watts NB; Van Horn L; Shikany JM; Rohan TE; Lane DS; Wild RA; Robles-Morales R; Shadyab AH; Saquib N; Cauley J
    Ann Intern Med; 2024 Apr; 177(4):428-438. PubMed ID: 38467003
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Plasma metabolites and risk of seven cancers: a two-sample Mendelian randomization study among European descendants.
    Chen Y; Xie Y; Ci H; Cheng Z; Kuang Y; Li S; Wang G; Qi Y; Tang J; Liu D; Li W; Yang Y
    BMC Med; 2024 Mar; 22(1):90. PubMed ID: 38433226
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration.
    Piscitelli J; Reddy MB; Wollenberg L; Del Frari L; Gong J; Wood L; Zhang Y; Matschke K; Williams JH
    Clin Pharmacokinet; 2024 Apr; 63(4):483-496. PubMed ID: 38424308
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Understanding Social, Cultural, and Religious Factors Influencing Medical Decision-Making on BRCA1/2 Genetic Testing in the Orthodox Jewish Community.
    Yi H; Trivedi MS; Crew KD; Schechter I; Appelbaum P; Chung WK; Allegrante JP; Kukafka R
    Public Health Genomics; 2024; 27(1):57-67. PubMed ID: 38402864
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Resistance Training-Induced Gains in Muscle Strength and Power Mediate the Improvement in Walking Speed in Middle-Aged Women Who Are breast cancer Survivors.
    Santagnello SB; Martins FM; de Oliveira Junior GN; de Sousa JFR; Nomelini RS; Murta EFC; Orsatti FL
    J Strength Cond Res; 2024 Apr; 38(4):773-782. PubMed ID: 38354372
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Improving lesion detection in mammograms by leveraging a Cycle-GAN-based lesion remover.
    Lee J; Nishikawa RM
    Breast Cancer Res; 2024 Feb; 26(1):21. PubMed ID: 38303004
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Superoxide Dismutase (rs2070424, rs4880, rs2536512) and Catalase (rs794316, rs1001179) SNPs and their Association with breast cancer Risk: Findings from a Hospital Based Case-Control Study.
    Datkhile KD; Gudur RA; Bhosale SJ; Gudur AK; Durgawale PP; Jagdale NJ; More AL; Patil SR
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):175-184. PubMed ID: 38285782
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Feasibility of measuring comorbidity indices based on clinical breast cancer records.
    Eslami B; Alipour S; Seyyedsalehi MS; Nahvijou A; Omranipour R; Rajabpour MV; Zendehdel K
    East Mediterr Health J; 2023 Nov; 26(11):870-876. PubMed ID: 38279882
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Exploring the Potential of Montmorillonite as an Antiproliferative Nanoagent against MDA-MB-231 and MCF-7 Human breast cancer Cells.
    Sabzevari AG; Sabahi H; Nikbakht M; Azizi M; Dianat-Moghadam H; Amoozgar Z
    Cells; 2024 Jan; 13(2):. PubMed ID: 38275825
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. cancer burden and risk in the Chinese population aged 55 years and above: A systematic analysis and comparison with the USA and Western Europe.
    Gao TY; Tao YT; Li HY; Liu X; Ma YT; Li HJ; Xian-Yu CY; Deng NJ; Leng WD; Luo J; Zhang C
    J Glob Health; 2024 Jan; 14():04014. PubMed ID: 38271210
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed, refractory mantle cell lymphoma.
    Grieve C; Joseph A; Drullinsky P; Zelenetz AD; Hamlin P; Kumar A
    Leuk Lymphoma; 2024 Feb; 65(2):235-241. PubMed ID: 38264906
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 129.